SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divis Laboratories’ unit undergoes inspection by US-FDA

03 Aug 2011 Evaluate

Divis Laboratories’ unit-1 at vill., Lingojigudem, Choutuppal Mandal near Hyderabad had been inspected by the US-FDA. The intention of this inspection was for product pre-approval and general current good manufacturing practices. The audit concluded with minor observations primarily about additional records for further improvement of existing records.

The company has registered a growth of 26.55% in its net profit for the year ended March 31, 2011 at Rs 435.57 crore as compared to Rs 344.20 crore for the year ended March 31, 2010. Its total income has increased by 40.00% at Rs 1344.04 crore for the year from Rs 959.98 crore in previous year.

Divis Lab Share Price

6228.95 -68.55 (-1.09%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×